Lanreotide
Title: Lanreotide
CAS Registry Number: 108736-35-2
CAS Name: 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2®7)-disulfide
Additional Names: angiopeptin
Manufacturers' Codes: DC 13-116; BIM-23014
Molecular Formula: C54H69N11O10S2
Molecular Weight: 1096.32
Percent Composition: C 59.16%, H 6.34%, N 14.05%, O 14.59%, S 5.85%
Literature References: Octapeptide somatostatin analog. Prepn: D. H. Coy et al., EP 215171; eidem, US 4853371 (1987, 1989 both to Tulane Educational Fund). Clinical pharmacokinetics and hormonal effects: J. M. Kuhn et al., Br. J. Clin. Pharmacol. 38, 213 (1994). Clinical evaluation in acromegaly: P. Caron et al., Eur. J. Endocrinol. 132, 320 (1995).
 
Derivative Type: Acetate
CAS Registry Number: 127984-74-1
Manufacturers' Codes: BIM-23014C
Trademarks: Somatuline LP (Ipsen)
Line Formula: C54H69N11O10S2.xC2H4O2
 
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic (Hormonal); Somatostatin Analog; Somatostatin Analog.

Others monographs:
PhloroglucinolCedrolHomoeriodictyolBromphenol Blue
2-AminopropanolDiphosgeneXenytropium BromideSabcomeline
Lupinine2-(2-Naphthyloxy)ethanolEpithiazidep-Toluenesulfinic Acid
tert-Butyl NitriteTiludronic AcidViehe's SaltMethyleneaminoacetonitrile
©2016 DrugLead US FDA&EMEA